INBX
Price
$75.80
Change
-$6.31 (-7.68%)
Updated
Feb 13 closing price
Capitalization
1.1B
36 days until earnings call
Intraday BUY SELL Signals
PRLD
Price
$2.23
Change
-$0.01 (-0.45%)
Updated
Feb 13 closing price
Capitalization
140.82M
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INBX vs PRLD

Header iconINBX vs PRLD Comparison
Open Charts INBX vs PRLDBanner chart's image
Inhibrx Biosciences
Price$75.80
Change-$6.31 (-7.68%)
Volume$137.47K
Capitalization1.1B
Prelude Therapeutics
Price$2.23
Change-$0.01 (-0.45%)
Volume$127.07K
Capitalization140.82M
INBX vs PRLD Comparison Chart in %
INBX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
INBX vs. PRLD commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (INBX: $75.80 vs. PRLD: $2.23)
Brand notoriety: INBX and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 62% vs. PRLD: 28%
Market capitalization -- INBX: $1.1B vs. PRLD: $140.82M
INBX [@Biotechnology] is valued at $1.1B. PRLD’s [@Biotechnology] market capitalization is $140.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whilePRLD’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • PRLD’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than PRLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while PRLD’s TA Score has 6 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 5 bearish.
  • PRLD’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than INBX.

Price Growth

INBX (@Biotechnology) experienced а -9.67% price change this week, while PRLD (@Biotechnology) price change was +2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

INBX is expected to report earnings on Mar 23, 2026.

PRLD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($1.1B) has a higher market cap than PRLD($141M). INBX YTD gains are higher at: -4.051 vs. PRLD (-23.103). PRLD has higher annual earnings (EBITDA): -119.27M vs. INBX (-143.46M). INBX has more cash in the bank: 153M vs. PRLD (55M). PRLD has less debt than INBX: PRLD (17.9M) vs INBX (107M). PRLD has higher revenues than INBX: PRLD (10.5M) vs INBX (1.4M).
INBXPRLDINBX / PRLD
Capitalization1.1B141M782%
EBITDA-143.46M-119.27M120%
Gain YTD-4.051-23.10318%
P/E Ratio0.20N/A-
Revenue1.4M10.5M13%
Total Cash153M55M278%
Total Debt107M17.9M598%
TECHNICAL ANALYSIS
Technical Analysis
INBXPRLD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KHNGY43.991.26
+2.95%
Kuehne & Nagel International AG
BKEAF1.95N/A
N/A
Bank of East Asia Limited
JSEJF8.96N/A
N/A
Jse Ltd.
SEGYY0.35N/A
N/A
SPT Energy Group Inc
AATV0.11-0.03
-21.21%
Adaptive Ad Systems, Inc.

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been closely correlated with ACET. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if INBX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-7.68%
ACET - INBX
86%
Closely correlated
+2.83%
IPSC - INBX
83%
Closely correlated
N/A
TERN - INBX
82%
Closely correlated
+0.11%
STRO - INBX
81%
Closely correlated
+3.46%
ATOS - INBX
81%
Closely correlated
+6.60%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with IPSC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
-0.45%
IPSC - PRLD
54%
Loosely correlated
N/A
IMNM - PRLD
54%
Loosely correlated
-1.25%
INBX - PRLD
53%
Loosely correlated
-7.68%
TRDA - PRLD
52%
Loosely correlated
+0.74%
ANNX - PRLD
52%
Loosely correlated
-5.78%
More